376 related articles for article (PubMed ID: 27908680)
1. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.
Labbate CV; Hensley PJ; Miest TS; Qiao W; Adibi M; Shah AY; Chery L; Papadopoulos J; Siefker-Radtke AO; Gao J; Guo CC; Czerniak BA; Navai N; Kamat AM; Dinney CP; Campbell MT; Matin SF
Urol Oncol; 2022 Oct; 40(10):454.e17-454.e23. PubMed ID: 35961847
[TBL] [Abstract][Full Text] [Related]
3. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hydronephrosis is associated with less decline in renal function after radical nephroureterectomy for upper tract urothelial carcinoma.
Singla N; Hutchinson R; Haddad A; Sagalowsky A; Lotan Y; Margulis V
Can J Urol; 2016 Aug; 23(4):8334-41. PubMed ID: 27544555
[TBL] [Abstract][Full Text] [Related]
5. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for impaired renal function following nephroureterectomy in upper urinary tract urothelial cell carcinoma.
Rodríguez Faba O; Palou J; Breda A; Maroto P; Fernández Gómez JM; Wong A; Villavicencio H
Urol Int; 2014; 92(2):169-73. PubMed ID: 24280761
[TBL] [Abstract][Full Text] [Related]
7. Advanced chronic kidney disease; A comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma.
Dudinec JV; Ortiz-Melo DI; Lipkin ME; Abern MR; Shah AM; Inman BA
Urol Oncol; 2023 Jun; 41(6):295.e19-295.e25. PubMed ID: 36526526
[TBL] [Abstract][Full Text] [Related]
8. Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma.
Tabayoyong W; Li R; Gao J; Kamat A
Urol Clin North Am; 2018 May; 45(2):155-167. PubMed ID: 29650132
[TBL] [Abstract][Full Text] [Related]
9. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy.
Shao IH; Lin YH; Hou CP; Juang HH; Chen CL; Chang PL; Tsui KH
Drug Des Devel Ther; 2014; 8():1985-90. PubMed ID: 25364228
[TBL] [Abstract][Full Text] [Related]
11. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
[TBL] [Abstract][Full Text] [Related]
13. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.
Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M
Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma.
Singla N; Gayed BA; Bagrodia A; Krabbe LM; Palazzi KL; Mirheydar H; Harrow B; Jacobs C; Youssef R; Darwish O; Sagalowsky A; Lotan Y; Derweesh I; Margulis V
Urol Oncol; 2015 Jun; 33(6):268.e1-7. PubMed ID: 25862284
[TBL] [Abstract][Full Text] [Related]
15. Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
Lu DD; Boorjian SA; Raman JD
Urol Oncol; 2017 Mar; 35(3):113.e1-113.e7. PubMed ID: 27884539
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.
Lane BR; Smith AK; Larson BT; Gong MC; Campbell SC; Raghavan D; Dreicer R; Hansel DE; Stephenson AJ
Cancer; 2010 Jun; 116(12):2967-73. PubMed ID: 20564402
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
[TBL] [Abstract][Full Text] [Related]
18. Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.
Thompson RH; Boorjian SA; Kim SP; Cheville JC; Thapa P; Tarrel R; Dronca R; Costello B; Frank I
BJU Int; 2014 May; 113(5b):E17-21. PubMed ID: 24006893
[TBL] [Abstract][Full Text] [Related]
19. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
20. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.
Kaag MG; O'Malley RL; O'Malley P; Godoy G; Chen M; Smaldone MC; Hrebinko RL; Raman JD; Bochner B; Dalbagni G; Stifelman MD; Taneja SS; Huang WC
Eur Urol; 2010 Oct; 58(4):581-7. PubMed ID: 20619530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
